Frontier
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 14, 2016; 22(42): 9257-9278
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9257
Table 3 Treatment considerations for investigation of gut-derived immune responses
Treatment ConsiderationNatureFindings
Dietary adjustmentsAnimal protein, saturated fats[90]Bacteroides, Firmicutes (including Clostridia), and Prevotella favored by different dietary regimens[37,90]
High carbohydrate diets[90]
Low fat high fiber diet[90]
Probiotic preparationsBifidobacterium bifidum[253]Expands Tregs in cell culture[278]
Lactobacillus strains[254,263,266]Prevents diabetes in NOD mice[263]
Lactobacillus rhamnosus[276]Improves liver tests in rat model[266]
Anaerostipes caccae[277]Increases tight junction proteins[276]
Consumes lactate and produces butyrate[277]
Vitamin A and retinoic acidRetinoic acid supplement[255]Restores Lactobacilli in lupus model[255]
Dietary vitamin A[256]Regulates cytokines in lupus model[256]
Induces IL-10-producing Tregs[279]
AntibioticsTetracycline, minocycline[257]Reduces activity in RA[257]
Vancomycin, metronidazole[269]Improves tests and pruritus in PSC[269]
Re-colonizationBacteroides fragilis[107]Induces Tregs in colitis model[107,109,110]
Fecal transplantationClostridia species[109,110]
Intestinal barrier protectorsGelatin tannate[258-260]Enhances mucus barrier[258,259]
Reduces activity in murine colitis[259]
Alters composition of microbiota[259]
Limits inflammatory effects of LPS[260]
Inhibits IL-8 and TNF-α in LPS cells[260]
TLR inhibitorsOligodeoxynucleotides blocking TLR7 signaling[261]Improves tests and reduces activity in murine model of lupus nephritis[261]
Improves autoimmune lung injury[261]
Molecular interventionsPolysaccharide A[105,262]Induces IL-10 producing Tregs[105,262]
Protects against EAE in mice[105]
Short chain fatty acidsAcetate, propionate, butyrate[200]Modulates gut signaling pathways[200]
Inhibits histone deacetylases[200,264]
Regulates gene expression[200]
Enhances gut integrity[200]